Search research articles
Contact Us
Filters
Showing results (51-60 of 106) with videos related to
Page
of 11
Sort By:
International Journal of Molecular Sciences
|
January 21, 2023
M3 Receptor Pathway Stimulates Rapid Transcription of the CB1 Receptor Activation through Calcium Signalling and the CNR1 Gene Promoter
Pietro Marini, Philip Cowie, Ahmet Ayar, et al.
Biochemical and Biophysical Research Communications
|
September 27, 2005
Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase
Séverine Vandevoorde, Bijali Saha, Anu Mahadevan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 7, 2005
Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors
Douglas McHugh, R Shannon McMaster, Roger G Pertwee, et al.
Journal of Cannabis Research
|
July 13, 2021
Assessing the treatment of cannabidiolic acid methyl ester: a stable synthetic analogue of cannabidiolic acid on c-Fos and NeuN expression in the hypothalamus of rats
Eric Murillo-Rodríguez, Diana Millán-Aldaco, Gloria Arankowsky-Sandoval, et al.
Psychopharmacology
|
January 19, 2011
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews
Erin M Rock, Jennifer M Goodwin, Cheryl L Limebeer, et al.
The Journal of Biological Chemistry
|
October 27, 2011
Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids
Sharon Anavi-Goffer, Gemma Baillie, Andrew J Irving, et al.
Biological Psychiatry
|
August 22, 2017
Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence
Richard A Slivicki, Zhili Xu, Pushkar M Kulkarni, et al.
Journal of Leukocyte Biology
|
June 1, 2007
Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis
Heping Xu, Ching L Cheng, Mei Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 23, 2002
Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide
Ruth A Ross, Susan J Craib, Lesley A Stevenson, et al.
Pharmacological Research
|
December 8, 2009
In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB(2) receptor inverse agonists
Maria Grazia Cascio, Daniele Bolognini, Roger G Pertwee, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 106) with videos related to
Sort By:
Page
of 11
International Journal of Molecular Sciences
|
January 21, 2023
M3 Receptor Pathway Stimulates Rapid Transcription of the CB1 Receptor Activation through Calcium Signalling and the CNR1 Gene Promoter
Pietro Marini, Philip Cowie, Ahmet Ayar, et al.
Biochemical and Biophysical Research Communications
|
September 27, 2005
Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase
Séverine Vandevoorde, Bijali Saha, Anu Mahadevan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 7, 2005
Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors
Douglas McHugh, R Shannon McMaster, Roger G Pertwee, et al.
Journal of Cannabis Research
|
July 13, 2021
Assessing the treatment of cannabidiolic acid methyl ester: a stable synthetic analogue of cannabidiolic acid on c-Fos and NeuN expression in the hypothalamus of rats
Eric Murillo-Rodríguez, Diana Millán-Aldaco, Gloria Arankowsky-Sandoval, et al.
Psychopharmacology
|
January 19, 2011
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews
Erin M Rock, Jennifer M Goodwin, Cheryl L Limebeer, et al.
The Journal of Biological Chemistry
|
October 27, 2011
Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids
Sharon Anavi-Goffer, Gemma Baillie, Andrew J Irving, et al.
Biological Psychiatry
|
August 22, 2017
Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence
Richard A Slivicki, Zhili Xu, Pushkar M Kulkarni, et al.
Journal of Leukocyte Biology
|
June 1, 2007
Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis
Heping Xu, Ching L Cheng, Mei Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 23, 2002
Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide
Ruth A Ross, Susan J Craib, Lesley A Stevenson, et al.
Pharmacological Research
|
December 8, 2009
In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB(2) receptor inverse agonists
Maria Grazia Cascio, Daniele Bolognini, Roger G Pertwee, et al.
Page
of 11